Empowering the entire R&D and commercialization value chain with a global vision, we are committed to joining hands with partners to co-create a new ecosystem for the pharmaceutical and healthcare industry.
Core Strengths:
- Standardized Listed Operation: As a publicly listed enterprise (002907.SZ), we adhere to standardized corporate governance and rigorous compliance systems. Supported by sound operational mechanisms and stable financial fundamentals, we deliver sustainable and high-quality corporate development.
- Strong Commercial Capability: Backed by an elite commercial team of over 500 professionals, we have established a comprehensive domestic and overseas commercial service network. We provide full-lifecycle market operation and channel management capabilities to drive continuous market penetration and product monetization.
- Professional Innovation R&D Platform: We operate a specialized subsidiary for innovative drug development, focusing on high-value therapeutic areas. By advancing new drug research, clinical development and industrialization, we build differentiated technological barriers and robust innovative product pipelines for long-term industrial competition.
We welcome global partners for diverse forms of strategic collaboration across innovative drugs, generics and CDMO/CMO services.
1. Innovative Drug Assets
We seek in-depth cooperation on our innovative drug pipelines via License-out, New Co and Co-development models. We are open to flexible collaboration frameworks to jointly advance R&D, clinical development and commercialization globally.
2. Generic Drugs
For generic pharmaceutical products, we offer License-out and Co-development opportunities to expand market presence across international territories.
3.CDMO / CMO Services
We operate tablet production lines compliant with FDA CGMP standards. With state-of-the-art manufacturing capabilities, we provide one-stop CDMO and CMO services to meet diversified production and processing demands of global clients.